The FDA asked for information on the stage 3 clinical trails (which is a normal thing to get) and instead of providing it they decided to go for full approval.

The FDA asked for information on the stage 3 clinical trails (which is a normal thing to get) and instead of providing it they decided to go for full approval. Which is really strange. Unclear why they would do that. https://www.hindustantimes.com/india-news/why-was-bharat-biotech-s-covaxin-covid-19-vaccine-not-approved-in-us-here-s-what-we-know-so-far-101623387176530.html https://www.hindustantimes.com/india-news/why-was-bharat-bio...